BEX3, a receptor-associated protein for the CSC marker CD271, is overexpressed in cisplatin-resistant NPC cells and is associated with drug resistance through the activation of the MAPK pathway [192]. This evidence concerns the gene BEX3 and nasopharyngeal carcinoma.